InvestorsHub Logo
Followers 833
Posts 119916
Boards Moderated 17
Alias Born 09/05/2002

Re: mm2k post# 70082

Tuesday, 06/05/2018 7:43:19 PM

Tuesday, June 05, 2018 7:43:19 PM

Post# of 108192
ADXS-NEO is using a traditional “3+3” trial design for each of the three cancer indications being tested:

http://onbiostatistics.blogspot.com/2015/01/phase-i-dose-escalation-study-design-3.html [scan down to see flowchart]

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News